- Home
- CGNT vs HQL Comparison
CGNT vs HQL Comparison
Compare CGNT & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGNT | HQL |
|---|---|---|
| Founded | 2020 | 1992 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Investment Managers |
| Sector | Technology | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.4M | 539.1M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGNT | HQL |
|---|---|---|
| Price | $8.26 | $18.33 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $12.33 | N/A |
| AVG Volume (30 Days) | ★ 488.9K | 103.5K |
| Earning Date | 12-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $11.71 | N/A |
| Revenue Next Year | $10.34 | N/A |
| P/E Ratio | ★ N/A | $23.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.29 | $15.66 |
| 52 Week High | $12.31 | $22.67 |
Technical Indicators
Market Signals| Indicator | CGNT | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 49.86 |
| Support Level | $8.00 | $17.13 |
| Resistance Level | $9.16 | $19.00 |
| Average True Range (ATR) | 0.46 | 0.60 |
| MACD | -0.13 | 0.09 |
| Stochastic Oscillator | 14.05 | 56.47 |
Price Performance
Historical ComparisonAbout CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.